Abstract
Fentanyl [N-(1-phenethyl-4-piperidinyl)propionanilide] is a popular narcotic analgesic agent that is clinically used worldwide. However, fentanyl and its several analogs have caused abuse and fatalities in humans due to overdosing and narrow therapeutic index. The present study reports the synthesis and comparative bioefficacy of fentanyl and its four analogs, viz., N-(1-propyl-4-piperidinyl)propionanilide (1), N-(1-(2-phenoxyethyl)-4-piperidinyl)propionanilide (2), N-(1-(3-phenoxypropyl)-4-piperidinyl)propionanilide (3) and N-(1-(2-cyanoethyl)-4-piperidinyl)propionanilide (4), where the phenethyl chain of fentanyl was replaced by different functional groups, viz., alkyl, ethereal, and nitrile moieties. The median lethal dose (LD50) of the compounds was determined by three different routes and all the analogs were found to be safer than fentanyl. Observational assessment on spontaneous activities of the central nervous system, peripheral nervous system, and autonomic nervous system revealed that all the analogs were similar to fentanyl. Further, the neurotoxic effects of all the analogs were reversed by naloxone hydrochloride (opioid antagonist), confirming that their effects were mediated through opioid receptors. Antinociceptive activity was displayed by all the compounds and their median effective dose (ED50) and analgesic potency ratio were more or less similar to fentanyl. The lowest ED50 (23.7) and the highest potency ratio (1.18) was observed in the case of 2. However, the maximum therapeutic index was afforded by 4. The study indicates the promising role of some new opioid analgesics.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Coderre TJ, Melzack R (1992) The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 12:3665–3670
Correa CR, Calixto JB (1993) Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse. Br J Pharmacol 110:193–198
Damas J, Liegeois JF (1999) The inflammatory reaction induced by formalin in the rat paw. Naunyn-Schmeidebergs Arch Pharmacol 359:220–227
Dixon WJ (1965) The up-and-down method for small samples. J Am Stat Assoc 60:967–978
Ellis A, Benson N, Machin I, Corradini L (2008). The rat formalin test: Can it predict neuropathic pain? In: Spink AJ, Ballintjin MR, Bogers ND, Grieco F, Loijens LWS, Noldus LPJJ, Smit G, Zimmerman PH (eds) Proceedings of measuring behavior, Maastricht, The Netherlands, August 26–29, pp 324–325
Fine PG (2004) Opioid insights: opioid-induced hyperalgesia and opioid rotation. J Pain Palliatcare Pharmacother 18:75–79
Gardocki JF, Yelnosky J (1964) A study of some of the pharmacological actions of fentanyl citrate. Toxicol Appl Pharmacol 6:48–62
Hallenbeck JL (2003) Palliative care perspective. Oxford University Press, Inc., New York
Helsley GC, Lunsford CD, Welstead WJ Jr, Boswell RF, Funderburk WH, Johnson DN (1969) Synthesis and analgetic activity of some 1-substituted 3-pyrrolidinylanilides and dihydrobenzoxazinones. J Med Chem 12:583–586
Higashikawa Y, Suzuki S (2008) Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure–analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues. Forensic Toxicol 26:1–5
Hug CC, Murphy MR (1981) Tissue redistribution of fentanyl and termination of its effects in rats. Anaesthesiology 55:369–375
Hunskar S, Hole K (1987) The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30:103–114
Irwin S (1964) Drug screening and evaluation of new compounds in animals. In: Nodin JH, Siegler PE (eds) Animal and clinical techniques in drug evaluation. Year Book Medical Publishers, Chicago, pp 36–54
Irwin S (1968) Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioural and physiologic state of the mouse. Psychopharmacologia (Berl) 13:222–257
Ivanović MD, Vučkovic S, Ristović Z, Mićović IV, Beleslin DB (1995) Behavioral effects of fentanyl in rats. Iugav Physiol Pharmacol Acta 31:195–199
Janssen PAJ (1965) 1-Aralkyl-4-(N-aryl carbonylamino)piperidines and related compounds. US Patent 3, 164 600
Johnson M (2009) MSDS on fentanyl citrate. Macfarlan Smith Limited, Edinburgh
Leavitt SB (2009) Opioid antagonists, naloxone & naltrexene-Aids for pain management. An overview of clinical evidence. Pain Treatment Topics, Glenview, IL, 60025. http://Pain-Topics.Org, 1–16
Litchfield JT Jr, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharm Exp Ther 96:99–113
Mather LE (1983) Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet 8:422–446
Matosiuk D, Fidecka S, Antkiewicz-Michaluk L, Lipkowski J, Dybala I, Koziol AE (2002) Synthesis and pharmacological activity of new carbonyl derivatives of 1-aryl-2-iminoimidazolidine. Part 2. Synthesis and pharmacological activity of 1,6-diaryl-5,7(1H)dioxo-2,3-dihydroimidazo[1,2-a][1,3,5]triazines. Eur J Med Chem 37:761–772
McGinty J, Friedman D (1988) Opioids in the hippocampus. Natl Inst Drug Abuse Res Monogr Ser 82:1–145
McNicol E, Boyce D, Schumann R, Carr D (2008) Mu-opioid antagonists for opioid-induced bowel dysfunction. Cochrane Database Syst Rev. CD006332. PMID 18425947
Mićović IV, Ivanović MD, Vuckovic SM, Prostran MŠ, Došen-Mićović L, Kiricojević VD (2000) The synthesis and preliminary pharmacological evaluation of 4-methyl fentanyl. Biorg Med Chem Letts 10:2011–2014
Perlikowska R, Fichna J, Claude de-Rego J, Gach K, Janecka A (2011) Kinetic studies of novel inhibitors of endomorphine degrading enzymes. Med Chem Res. doi:10.1007/s00044-011-9666-5
Qi H, Li W, Qiu Y, Cui Y, Ma J, Gao X, Zeng Y, Yang J, Tang Y, Wang X, Sheng W, Xie Q, Liu J, Qiu Z, Chen H (2011) Synthesis and evaluation of k-opioid receptor agonistic activity and antinociceptive effect of novel morphine analogues, 7α-phenyl-6α, 14α-endo-etheno-tetrahydrothebaine with substituted o-, m- and p-amino group. Med Chem Res 20:1364–1370. doi:10.1007/s00044-010-9471-6
Shibata M, Ohkubo T, Takashi H, Inoki R (1989) Modified formalin test. Pain 38:345–352
Van Bever WFM, Niemegeers CJE, Janssen PAJ (1974) Synthetic analgesics. Synthesis and pharmacology of the diastereoisomers of N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide and N-[3- methyl-1-(1-methyl-2-phenylethyl)-4-piperidyl]-N-phenylpropanamide. J Med Chem 17:1047–1051
Van Nimmen NFJ, Poels KLC, Veulemans HAF (2004) Highly sensitive gas chromatographic-mass spectrometric screening method for the determination of pictogram levels of fentanyl, sufentanil and alfentanil and their major metabolites in urine of opioid exposed workers. J Chromat B 804:375–387
Vogel HG (2002) Psychotropic and neurotropic activity. In: Drug discovery and evaluation. Pharmacological assays. Springer, Berlin
Vučkovic S, Ivanović M, Prostran M, Todorović Z, Ristović Z, Mićović I, Beleslin D (1998) Higher environmental temperature potentiates cataleptic effect of fentanyl. Jpn J Pharmacol 78:523–527
Vučkovic S, Prostran M, Ivanović M, Dosen-Mićović L, Vujović KS, Vucetic C, Kadija M, Mićović Z (2011) Pharmacological evaluation of 3-carbomethoxy fentanyl in mice. Pharmaceuticals 4:233–243
Acknowledgments
The authors thank Prof. (Dr.) M.P. Kaushik, Director, DRDE, Gwalior, for his support and encouragement.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gupta, P.K., Yadav, S.K., Bhutia, Y.D. et al. Synthesis and comparative bioefficacy of N-(1-phenethyl-4-piperidinyl)propionanilide (fentanyl) and its 1-substituted analogs in Swiss albino mice. Med Chem Res 22, 3888–3896 (2013). https://doi.org/10.1007/s00044-012-0390-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-012-0390-6